Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Ocugen Inc/

Recent news which mentions Ocugen Inc/

Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
Tickers INNO
Tags Baudax Bio Inc/ Incyte Corp/ GlaxoSmithKline PLC
From Business Journals
Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds
Tickers INNO
Tags John Karanicolas Doug Manion Incyte Corp/
From Business Journals
Lab Notes: Wedgewood Pharmacy acquires Colorado lab; Aprea Therapeutics raises $5.5M
Tickers INNO
Tags Michael Travis Jennifer Travis Chris Mirabelli
From Business Journals
Lab Notes: Drexel and Bancroft team up to advance autism research; AmerisourceBergen forms new partnership
Tickers INNO
Tags AmerisourceBergen Corporation Matt Glucksmann Drexel University
From Business Journals
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
Tickers INNO
Tags Avantor Inc/ Annovis Bio Inc/ Michael Christie
From Business Journals
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
Tickers INNO
Tags Vincent Milano Armando Anido Biotech
From Business Journals
Lab Notes: Cabaletta signs licensing deal for up to $162M; merger unites life sciences tech providers
Tickers INNO
Tags Athena Countouriotis Inovio Pharmaceuticals Inc/ Biotech
From Business Journals
Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding
Tickers INNO
Tags Hristelina Ilieva Kulicke and Soffa Industries Inc/ Galera Therapeutics Inc/
From Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
Tags Coronavirus Insurance Biotech
From Business Journals
Lab Notes: Endo gets U.S. rights to potential knee pain drug; Optinose stock climbs after positive study results
Tickers INNO
Tags Roundup OptiNose Inc/ Biotech
From Business Journals
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech
Tags Shankar Musunuri Pharmaceuticals Ocugen Inc/
From Business Journals
Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat
Tags Health Care Coronavirus Biotech
From Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
Tickers INNO
Tags Medical Devices Jim Moran Christopher J/ Burns
From Business Journals
Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice
Tickers INNO
Tags Tim Crew Recro Pharma Inc/ Biotech
From Business Journals
Ocugen's stock plummets after FDA rejects emergency use bid for Covid vaccine
Tags Ocugen Inc/ Pharmaceuticals Insurance
From Business Journals
Ocugen expects $53.5M from stock sale amid efforts to bring Covaxin to the U.S.
Tags Pharmaceuticals Ocugen Inc/ Coronavirus
From Business Journals
Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant
Tags Pharmaceuticals Ocugen Inc/ Biotech
From Business Journals
Lab Notes: Strata Skin Sciences makes acquisition; Cabaletta Bio promotes 2 executives
Tickers INNO
Tags Arun Das Madrigal Pharmaceuticals Inc/ Biotech
From Business Journals
Lab Notes: Trevena advances new pain drug; Ocugen receives good news from FDA
Tickers INNO
Tags Harmony Biosciences Holdings Inc/ Trevena Inc/ Biotech
From Business Journals
FDA places a hold on Ocugen's plan for U.S. trials of the Covid-19 vaccine Covaxin
Tags Ocugen Inc/ Pharmaceuticals Coronavirus
From Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
Tags Shankar Musunuri Ocugen Biotech
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
Tickers INNO
Tags Roundup Craig Fraser OptiNose Inc/
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.